Psilocybin was classified as a ‘Schedule-1’ drug and deemed to be harmful and devoid of any medical benefits. The stigma associated with the use of magic mushrooms and psychedelics lasted for decades after which a resurgence came about with new clinical trials with promising results. It was a long dark age during which the only accepted treatment for mental health conditions was anti-depressants. Finally, a long-acting, natural alternative has appeared in the form of psilocybin that saves users from side effects and withdrawal symptoms of traditional anti-depressants.
Patients suffering from depression are given a dose of psilocybin that causes a powerful trip of about a few hours. The tests are performed in a controlled environment under supervision. These participants don’t have fun during the trip. They often recall the most terrible experiences in their lives. But they are prepared for what they are going to experience.
In a clinical trial, patients responded to psilocybin doses and showed rapid and long-acting results in their mental health. They did not need anti-depressants for a few weeks after the dose. Tests performed after some months showed they had got relief from many symptoms. Anecdotal reports suggest drastic improvements on mental health. People say magic mushrooms helped when no other therapies helped with depression.
The Social Impact
Despite so much evidence, many scientists and professionals deny accepting the therapeutic effects of psilocybin. Doctors have always warned people of the dangers associated with shrooms and they can be real if used in uncontrolled settings. However, when administered in a controlled environment, magic mushrooms have a lot of potential for patients suffering from conditions like anxiety, depression and addiction. This treatment is more effective than conventional anti-depressants.
Literature Related to Psilocybin
Around 2006, the first wave of awareness about drug was spread. Until then, it was considered a dangerous drug. When looked deep into the history of medicine, huge research was seen buried on this topic. A lot of research was performed about psychedelics in the 50s, 60s and 70s. The reports focused on the use of this drug to treat alcohol addiction. However, the classification of the drug made it difficult to carry out further research. The first-ever study suggested the effectiveness of the compound on cancer rather than depression or addiction.
Psilocybin and Cancer
This life-threatening disease is quite scary. Patients diagnosed with cancer often get emotional distress and start feeling hopeless and depressed. It is difficult to treat psychological distress associated with these conditions. Few years back, a clinical trial was performed that suggested that psilocybin reduces anxiety and depression in cancer patients. It was found that the drug helped participants change their conception of cancer and understand it as a part of their life. Many of them found the experience extremely connecting and healing. An increased number of neurons in the brain start interacting with each other under the effect of magic mushrooms. This would not have happened earlier because the mind followed a fixed pattern of thinking. This means psychedelics can add flexibility. The drug can also be effective at treating other conditions like obsessive-compulsive disorder, personality disorders and PTSD.